Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Jan;77(1):567–571. doi: 10.1073/pnas.77.1.567

Specific binding of phorbol ester tumor promoters

Paul E Driedger 1, Peter M Blumberg 1,*
PMCID: PMC348314  PMID: 6965793

Abstract

[20-3H]Phorbol 12,13-dibutyrate bound to particulate preparations from chicken embryo fibroblasts in a specific, saturable, reversible fashion. Equilibrium binding occurred with a Kd of 25 nM; this value is very close to the 50% effective dose (ED50), 50 nM, previously determined for the biological response (induction of fibronectin loss) in growing chicken embryo fibroblasts. At saturation, 1.4 pmol of [20-3H]phorbol 12,13-dibutyrate was bound per mg of protein (approximately 7 × 104 molecules per cell). Binding was inhibited by phorbol 12-myristate 13-acetate (Ki = 2 nM), mezerein (Ki = 180 nM), phorbol 12,13-dibenzoate (Ki = 180 nM), phorbol 12,13-diacetate (Ki = 1.7 μM), phorbol 12,13,20-triacetate (Ki = 39 μM), and phorbol 13-acetate (Ki = 120 μM). The measured Ki values are all within a factor of 3.5 of the ED50 values of these derivatives for inducing loss of fibronectin in intact cells. Binding was not inhibited by the inactive compounds phorbol (10 μg/ml) and 4α-phorbol 12,13-didecanoate (10 μg/ml) or by the inflammatory but nonpromoting phorbol-related diterpene esters resiniferatoxin (100 ng/ml) and 12-deoxyphorbol 13-isobutyrate 20-acetate (100 ng/ml). These data suggest that biological responses to the phorbol esters in chicken embryo fibroblasts are mediated by this binding activity and that the binding activity corresponds to the phorbol ester target in mouse skin involved in tumor promotion. Binding was not inhibited by the nonphorbol promoters anthralin (1 μM), phenol (1 mM), iodoacetic acid (1.7 μM), and cantharidin (75 μM), or by epidermal growth factor (100 ng/ml), dexamethasone acetate (2 μM), retinoic acid (10 μM), or prostaglandin E2 (1 μM). These agents thus appear to act at a target distinct from that of the phorbol esters.

Keywords: carcinogenesis, receptors, chicken embryo fibroblasts

Full text

PDF
567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belman S., Troll W. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res. 1972 Mar;32(3):450–454. [PubMed] [Google Scholar]
  2. Berry D. L., Bracken W. M., Fischer S. M., Viaje A., Slaga T. J. Metabolic conversion of 12-O-tetradecanoylphorbol-13-acetate in adult and newborn mouse skin and mouse liver microsomes. Cancer Res. 1978 Aug;38(8):2301–2306. [PubMed] [Google Scholar]
  3. Blumberg P. M., Driedger P. E., Rossow P. W. Effect of a phorbol ester on a transformation-sensitive surface protein of chick fibroblasts. Nature. 1976 Dec 2;264(5585):446–447. doi: 10.1038/264446a0. [DOI] [PubMed] [Google Scholar]
  4. Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. doi: 10.3109/10408447309025704. [DOI] [PubMed] [Google Scholar]
  5. Brown K. D., Dicker P., Rozengurt E. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1037–1043. doi: 10.1016/0006-291x(79)90221-3. [DOI] [PubMed] [Google Scholar]
  6. Delclos K. B., Blumberg P. M. Decrease in collagen production in normal and Rous sarcoma virus-transformed chick embryo fibroblasts induced by phorbol myristate acetate. Cancer Res. 1979 May;39(5):1667–1672. [PubMed] [Google Scholar]
  7. Diamond L., O'Brien T. G., Rovera G. Tumor promoters: effects on proliferation and differentiation of cells in culture. Life Sci. 1978 Nov 13;23(20):1979–1988. doi: 10.1016/0024-3205(78)90229-1. [DOI] [PubMed] [Google Scholar]
  8. Driedger P. E., Blumberg P. M. Non-phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts. Int J Cancer. 1978 Jul 15;22(1):63–69. doi: 10.1002/ijc.2910220113. [DOI] [PubMed] [Google Scholar]
  9. Driedger P. E., Blumberg P. M. Quantitative correlation between in vitro and in vivo activities of phorbol esters. Cancer Res. 1979 Mar;39(3):714–719. [PubMed] [Google Scholar]
  10. Driedger P. E., Blumberg P. M. The effect of phorbol diesters on chicken embryo fibroblasts. Cancer Res. 1977 Sep;37(9):3257–3265. [PubMed] [Google Scholar]
  11. Fisher P. B., Flamm M., Schachter D., Weinstein I. B. Tumor promoters induce membrane changes detected by fluorescence polarization. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1063–1068. doi: 10.1016/0006-291x(79)90225-0. [DOI] [PubMed] [Google Scholar]
  12. Goerttler K., Loehrke H., Schweizer J., Hesse B. Systemic two-stage carcinogenesis in the epithelium of the forestomach of mice using 7,12-dimethylbenz(a)anthracene as initiator and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter. Cancer Res. 1979 Apr;39(4):1293–1297. [PubMed] [Google Scholar]
  13. Hecker E., Schmidt R. Phorbolesters--the irritants and cocarcinogens of Croton Tiglium L. Fortschr Chem Org Naturst. 1974;31(0):377–467. doi: 10.1007/978-3-7091-7094-6_7. [DOI] [PubMed] [Google Scholar]
  14. Hergenhahn M., Kusumoto S., Hecker E. Diterpene esters from 'Euphorbium' and their irritant and cocarcinogenic activity. Experientia. 1974 Dec 15;30(12):1438–1440. doi: 10.1007/BF01919683. [DOI] [PubMed] [Google Scholar]
  15. Jacobson K., Wenner C. E., Kemp G., Papahadjopoulos D. Surface properties of phorbol esters and their interaction with lipid monolayers and bilayers. Cancer Res. 1975 Nov;35(11 Pt 1):2991–2995. [PubMed] [Google Scholar]
  16. Kreibich G., Hecker E. Active principles of croton oil. X. Preparation of tritium labeled croton oil factor A1 and other tritium labeled phorbol derivatives. Z Krebsforsch. 1970;74(4):448–456. [PubMed] [Google Scholar]
  17. Kubinyi H. Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model. Arzneimittelforschung. 1976;26(11):1991–1997. [PubMed] [Google Scholar]
  18. Kupchan S. M., Shizuri Y., Sumner W. C., Jr, Haynes H. R., Leighton A. P., Sickles B. R. Isolation and structural elucidation of new potent antileukemic diterpenoid esters from Gnidia species. J Org Chem. 1976 Nov 26;41(24):3850–3853. doi: 10.1021/jo00886a016. [DOI] [PubMed] [Google Scholar]
  19. Lee L. S., Weinstein I. B. Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature. 1978 Aug 17;274(5672):696–697. doi: 10.1038/274696a0. [DOI] [PubMed] [Google Scholar]
  20. Lee L. S., Weinstein I. B. Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science. 1978 Oct 20;202(4365):313–315. doi: 10.1126/science.308698. [DOI] [PubMed] [Google Scholar]
  21. Mufson R. A., Laskin J. D., Fisher P. B., Weinstein I. B. Melittin shares certain cellular effects with phorbol ester tumour promoters. Nature. 1979 Jul 5;280(5717):72–74. doi: 10.1038/280072a0. [DOI] [PubMed] [Google Scholar]
  22. Schweizer J., Loehrke H., Goerttler K. Transmaternal modification of the Berenblum/Mottram experiment in mice. Bull Cancer. 1978;65(3):265–270. [PubMed] [Google Scholar]
  23. Scribner J. D., Süss R. Tumor initiation and promotion. Int Rev Exp Pathol. 1978;18:137–198. [PubMed] [Google Scholar]
  24. Shoyab M., De Larco J. E., Todaro G. J. Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature. 1979 May 31;279(5712):387–391. doi: 10.1038/279387a0. [DOI] [PubMed] [Google Scholar]
  25. Smythies J. R., Benington F., Morin R. D. On the molecular structure of receptors for co-carcinogens and some anti-cancer drugs. Psychoneuroendocrinology. 1975;1(2):123–130. doi: 10.1016/0306-4530(75)90004-9. [DOI] [PubMed] [Google Scholar]
  26. Van Duuren B. L. Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res. 1969;11:31–68. doi: 10.1159/000391388. [DOI] [PubMed] [Google Scholar]
  27. Verma A. K., Boutwell R. K. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res. 1977 Jul;37(7 Pt 1):2196–2201. [PubMed] [Google Scholar]
  28. Wilson S. R., Huffman J. C. The structural relationship of phorbol and cortisol: a possible mechanism for the tumor promoting activity of phorbol. Experientia. 1976 Dec 15;32(12):1489–1490. doi: 10.1007/BF01924408. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES